{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T11:24:58Z","timestamp":1715858698937},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med. China"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11684-010-0093-7","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T04:00:32Z","timestamp":1280980832000},"page":"290-293","source":"Crossref","is-referenced-by-count":3,"title":["How to judge the association of postmenopausal hormone therapy and the risk of breast cancer"],"prefix":"10.1007","volume":"4","author":[{"given":"Ling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"issue":"2","key":"93_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2009.07.015","volume":"64","author":"H. M. Verkooijen","year":"2009","unstructured":"Verkooijen H M, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas, 2009, 64(2): 80\u201385","journal-title":"Maturitas"},{"issue":"5","key":"93_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejca.2010.01.003","volume":"46","author":"K. H. Sharpe","year":"2010","unstructured":"Sharpe K H, McClements P, Clark D I, Collins J, Springbett A, Brewster D H. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy. Eur J Cancer, 2010, 46(5): 937\u2013943","journal-title":"Eur J Cancer"},{"issue":"9","key":"93_CR3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2009.01.016","volume":"45","author":"D. M. Parkin","year":"2009","unstructured":"Parkin D M. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer, 2009, 45(9): 1649\u20131653","journal-title":"Eur J Cancer"},{"issue":"2","key":"93_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000201677","volume":"76","author":"A. Katalinic","year":"2009","unstructured":"Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence- results from the German Network of Cancer Registries. Pathobiology, 2009, 76(2): 90\u201397","journal-title":"Pathobiology"},{"issue":"3","key":"93_CR5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/bcr1672","volume":"9","author":"A. Jemal","year":"2007","unstructured":"Jemal A, Ward E, Thun M. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res, 2007, 9(3): 108","journal-title":"Breast Cancer Res"},{"issue":"11","key":"93_CR6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5694\/j.1326-5377.2008.tb01821.x","volume":"188","author":"K. Canfell","year":"2008","unstructured":"Canfell K, Banks E, Moa A M, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust, 2008, 188(11): 641\u2013644","journal-title":"Med J Aust"},{"issue":"3","key":"93_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators.","year":"2002","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progesterone in healthy postmenopausal women. JAMA, 2002, 288(3): 321\u2013333","journal-title":"JAMA"},{"issue":"3","key":"93_CR8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.maturitas.2009.11.015","volume":"65","author":"K. E. Huang","year":"2010","unstructured":"Huang K E, Xu L, I N N, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas, 2010, 65(3): 276\u2013283","journal-title":"Maturitas"},{"issue":"5","key":"93_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/EDE.0b013e3181a71279","volume":"20","author":"R. Gramling","year":"2009","unstructured":"Gramling R, Eaton C B, Rothman K J, Cabral H, Silliman R A, Lash T L. Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women. Epidemiology, 2009, 20(5): 752\u2013756","journal-title":"Epidemiology"},{"issue":"3","key":"93_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701401073","volume":"10","author":"A. Pines","year":"2007","unstructured":"Pines A, Sturdee D W, Birkh\u00e4user M H, Schneider H P, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric, 2007, 10(3): 181\u2013194","journal-title":"Climacteric"},{"issue":"3","key":"93_CR11","first-page":"498","volume":"98","author":"T. L. Bush","year":"2001","unstructured":"Bush T L, Whiteman M, Flaws J A. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol, 2001, 98(3): 498\u2013508","journal-title":"Obstet Gynecol"},{"issue":"24","key":"93_CR12","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"R. T. Chlebowski","year":"2003","unstructured":"Chlebowski R T, Hendrix S L, Langer R D, Stefanick M L, Gass M, Lane D, Rodabough R J, Gilligan M A, Cyr M G, Thomson C A, Khandekar J, Petrovitch H, McTiernan A; WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative randomized trial. JAMA, 2003, 289(24): 3243\u20133253","journal-title":"JAMA"},{"issue":"9382","key":"93_CR13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","volume":"362","author":"V. f. t. Beral","year":"2003","unstructured":"Beral V, for the Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 2003, 362(9382): 419\u2013427","journal-title":"Lancet"},{"issue":"14","key":"93_CR14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1775","volume":"291","author":"G. L. Anderson","year":"2004","unstructured":"Anderson G L, Limacher M, Assaf A R, Bassford T, Beresford S A, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard B V, Hsia J, Hubbell A, Jackson R, Johnson K C, Judd H, Kotchen J M, Kuller L, LaCroix A Z, Lane D, Langer R D, Lasser N, Lewis C E, Manson J, Margolis K, Ockene J, O\u2019sullivan M J, Phillips L, Prentice R L, Ritenbaugh C, Robbins J, Rossouw J E, Sarto G, Stefanick M L, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women\u2019s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 2004, 291(14): 1701\u20131712","journal-title":"JAMA"},{"issue":"9084","key":"93_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer.","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 1997, 350(9084): 1047\u20131059 Erratum in. Lancet, 1997, 350(9089): 1484","journal-title":"Lancet"},{"issue":"24","key":"93_CR16","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","volume":"289","author":"C. I. Li","year":"2003","unstructured":"Li C I, Malone K E, Porter P L, Weiss N S, Tang M T, Cushing-Haugen K L, Daling J R. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA, 2003, 289(24): 3254\u20133263","journal-title":"JAMA"},{"issue":"12","key":"93_CR17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/09513590903056878","volume":"25","author":"A. Gadducci","year":"2009","unstructured":"Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani A R. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue. Gynecol Endocrinol, 2009, 25(12): 807\u2013815","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"93_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/17455057.4.3.207","volume":"4","author":"R. J. Santen","year":"2008","unstructured":"Santen R J. Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones? Womens Health (Lond Engl), 2008, 4(3): 207\u2013210","journal-title":"Womens Health (Lond Engl)"},{"issue":"9","key":"93_CR19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","volume":"80","author":"H. Jernstr\u00f6m","year":"1999","unstructured":"Jernstr\u00f6m H, Frenander J, Fern\u00f6 M, Olsson H. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer, 1999, 80(9): 1453\u20131458","journal-title":"Br J Cancer"},{"issue":"2","key":"93_CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mob.2002.121077","volume":"186","author":"K. Nanda","year":"2002","unstructured":"Nanda K, Bastian L A, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: a systematic review. Am J Obstet Gynecol, 2002, 186(2): 325\u2013334","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"93_CR21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","volume":"166","author":"W. Y. Chen","year":"2006","unstructured":"Chen W Y, Manson J E, Hankinson S E, Rosner B, Holmes M D, Willett W C, Colditz G A. Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med, 2006, 166(9): 1027\u20131032","journal-title":"Arch Intern Med"},{"issue":"6","key":"93_CR22","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1200\/JCO.1999.17.6.1680","volume":"17","author":"B. Fowble","year":"1999","unstructured":"Fowble B, Hanlon A, Freedman G, Patchefsky A, Kessler H, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J Clin Oncol, 1999, 17(6): 1680\u20131688","journal-title":"J Clin Oncol"},{"issue":"6","key":"93_CR23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","volume":"360","author":"R. T. Chlebowski","year":"2009","unstructured":"Chlebowski R T, Kuller L H, Prentice R L, Stefanick M L, Manson J E, Gass M, Aragaki A K, Ockene J K, Lane D S, Sarto G E, Rajkovic A, Schenken R, Hendrix S L, Ravdin P M, Rohan T E, Yasmeen S, Anderson G, for the WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med, 2009, 360(6): 573\u2013587","journal-title":"N Engl J Med"}],"container-title":["Frontiers of Medicine in China"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-010-0093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-010-0093-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-010-0093-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T01:31:54Z","timestamp":1591752714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-010-0093-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s11684-010-0093-7","relation":{},"ISSN":["1673-7342","1673-7458"],"issn-type":[{"value":"1673-7342","type":"print"},{"value":"1673-7458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}